Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
Main Authors: | Kim M. A. De Kleijn, Gerard J. M. Martens |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=10;spage=2023;epage=2025;aulast=De |
Similar Items
-
NUCLEAR FACTOR KAPPA B AS A POTENTIAL TARGET FOR PHARMACOLOGICAL CORRECTION ENDOTHELIUM-ASSOCIATED PATHOLOGY
by: Vera Ragulina, et al.
Published: (2017-03-01) -
Nuclear Factor-kappa B Signalling in Human Myometrium
by: Lindstrom, Tamsin Maria
Published: (2007) -
Targeting Nuclear Factor-kappa B to overcome resistance to chemotherapy.
by: Peter eGodwin, et al.
Published: (2013-05-01) -
Synthesis and physicochemical characterization of novel phenotypic probes targeting the nuclear factor-kappa B signaling pathway
by: Paul M. Hershberger, et al.
Published: (2013-05-01) -
Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System
by: Kim M. A. De Kleijn, et al.
Published: (2020-06-01)